250682-08-7

Basic information

• Product Name: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid
• Synonyms: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid
• CAS NO: 250682-08-7
• Molecular Formula: C₁₂H₁₂F₃NO₃
• Molecular Weight: 275.2237896
• Mol File: 250682-08-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid(250682-08-7)
• EPA Substance Registry System: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid(250682-08-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 250682-08-7(Hazardous Substances Data)

Upstream product

• 149793-69-1 3-fluoro-5-trifluoromethyl-benzonitrile 
• 250682-12-3 ethyl 3-fluoro-5-(trifluoromethyl)benzoate 
• 250682-07-6 3-morpholin-4-yl-5-trifluoromethyl-benzoic acid ethyl ester 
• 220954-14-3 3-(4-morpholinyl)-5-(trifluoromethyl)-benzonitrile 

Downstream Products

• 677704-47-1 N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-(4-morpholinyl)-5-(trifluoromethyl)-benzamide 
• 1095274-40-0 {5-[3-(4-morpholinyl)-5-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}acetaic acid 
• 1095274-39-7 ethyl {5-[3-(4-morpholinyl)-5-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}acetate 
• 1095273-34-9 1-[1-({5-[3-(4-morpholinyl)-5-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}acetyl)-4-piperidinyl]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one 
• 263269-59-6 N-[4-methyl-3-(3-morpholino-5-trifluoromethylbenzamido)phenyl]-2-morpholinopyridine-4-carboxamide 
• 250682-10-1 N-(4-methyl-3-nitro-phenyl)-3-morpholin-4-yl-5-trifluoromethyl-benzamide 
• 250682-06-5 N-(3-amino-4-methylphenyl)-3-morpholino-5-trifluoromethylbenzamide 
• 250682-09-8 3-Morpholino-5-trifluoromethylbenzoyl chloride 
• 1360816-11-0 C₁₄H₁₈F₃N₃O₂ 
• 1350454-99-7 N-(2-(4-(6-(3-hydroxyphenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-3-(trifluoromethyl)-5-morpholinobenzamide 
• 1350454-86-2 N-(2-(4-(6-(3-methoxyphenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-3-(trifluoromethyl)-5-morpholinobenzamide 
• 1261242-35-6 N-(2-((4-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-yl)amino)ethyl)-3-morpholino-5-(trifluoromethyl)benzamide 

Relevant articles and documents

Novel imidazole derivatives

The invention is concerned with novel imidazole derivatives of formula (I), wherein m, E, R1, R2, R3, R4, R5, R6 and R7 are as defined in the description and in the claims, as we

COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF MALARIA

The invention provides a class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent malaria.

5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.

HETEROARYL DERIVATIVES AS CYTOKINE INHIBITORS

The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cyt

HETEROCYCLIC CYTOKINE INHIBITORS

The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory, anti-pain or anti-cancer agents. There are further provided m

NOVEL PYRIMIDINEAMIDE DERIVATIVES AND THE USE THEREOF

The invention relates to novel substituted N-(3-benzoylaminophenyl)-4-pyridyl-2-pyrimidinarnine derivatives, processes for the preparation thereof, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more oth

AMIDE DERIVATIVES

The invention concerns amide derivatives of Formula (Ia) wherein X is -NHCO- or -CONH-; m is 0-3; R1 is a group such as hydroxy, halogeno, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy and carbamoyl; n is 0-2; R2 is a group

BEZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES

The invention concerns the use of amide derivatives of formula (I) wherein: R1 and R2 are substituents such as hydroxy, C1-6alkoxy, mercapto, C1-6alkylthio, amino, C1-6alkylamino and di-(C1-6alkyl)amino; m and p are independently 0-3; R3 is C1-4alkyl; q is 0-4; and R4 is aryl or cycloalkyl; or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for use in the treatment of diseases or medical conditions mediated by cytokines

BENZAMIDE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS

The invention concerns amide derivatives of formula (I) wherein R 3 is (1-6C)alkyl or halogeno; m is 0-3, p is 0-2 and q is 0-4; each of R 1 and R 2 is a group such as hydroxy, halogeno, trifluoromethyl and cyano; R 4 is a basic group such as amino, (1-6C)alkylamino, di-[(1-6C)alkyl]amino, di-[(1-6C)alkyl]amino-(1-6C)alkyl, di-[(1-6C)alkyl]amino-(2-6C)alkoxy, heteroaryl, heteroaryloxy, heteroaryl-(1-6C)alkoxy, heterocyclyl, heterocyclyloxy and heterocyclyl-(1-6C)alkoxy; and Q 2 is a group such as heteroaryl, heteroaryloxy or heteroaryl-(1-6C)alkoxy which is optionally substituted; or pharmaceutically-acceptable salts or in-vivo-cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.